To noninvasively map sentinel lymph nodes (SLNs) and lymphatic vessels in rats in vivo by using dual-modality nonionizing imaging-volumetric spectroscopic photoacoustic imaging, which measures optical absorption, and planar fl uorescence imaging, which measures fl uorescent emission-of indocyanine green (ICG).
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Sprague-Dawley rats that weighed 250 2 420 g (age range, 60 2 120 days; fi ve rats for photoacoustic imaging and three for fl uorescence imaging) were used in all imaging experiments. First, the rats were given a mixture of ketamine (Ketaset; Fort Dodge Animal Health, Fort Dodge, Iowa) (85 mg per kilogram of body weight) and xylazine (AnaSed; Akorn, Decatur, Ill) (15 mg/kg) for anesthesia. After depilation of the axillary region, the rats were positioned atop a homemade holder. During the experiments, the rats were fully anesthetized by using a vaporized isofl urane system (Euthanex, Palmer, Pa) that provided 1 L/min oxygen and 0.75% isofl urane; their vital signs were managed by using a pulse oximeter. After image acquisition, the animals were euthanized with an overdose of pentobarbital (Sleepaway; Fort Dodge Animal Health); the SLNs were then dissected for visual verifi cation of ICG uptake. ICG (as 0.2 mL of 1 mmol/L ICG [Cardiogreen; Sigma-Aldrich, St Louis, Mo]) was injected intradermally into the left forepaw pad of the rat. Figure 1 c shows the optical spectrum of 1 mmol/L ICG ( 14 ) .
well as the maximum imaging depth, is scalable with ultrasonic frequency within the reach of diffuse photons. In biologic tissues the imaging depth can be up to a few centimeters deep. Methylene blue and gold nanoparticles have been applied to identify SLNs in rats with photoacoustic imaging ( 11, 12 ) . However, light is slightly more strongly scattered at the peak absorption wavelength of methylene blue, 677 nm, than light in the nearinfrared region. The methylene blue dye can cause chemical mastitis, as well as photodamage under intense light. Furthermore, gold nanoparticles are not yet approved by the U.S. Food and Drug Administration for clinical applications.
To date, to our knowledge, no studies have been reported about the feasibility of photoacoustic imaging with indocyanine green (ICG) for identifying SLNs and lymphatic vessels. ICG is Food and Drug Administration-approved for determining human cardiac output, hepatic function, and blood fl ow and for ophthalmic angiography. Because ICG has a moderate fl uorescence quantum yield (approximately 10%) and because fl uorescence and photoacoustic signals increase and decrease with the fl uorescence quantum yield, respectively, ICG can be used as a contrast agent for both fl uorescence imaging ( 13 ) and photoacoustic imaging. Thus, the purpose of this study was to noninvasively map SLNs and lymphatic vessels in rats in vivo by using dualmodality (volumetric spectroscopic photoacoustic imaging, which measures optical absorption, and planar fl uorescence imaging, which measures fl uorescent emission) nonionizing imaging of ICG.
Materials and Methods

Animal Handling and Dye Preparation
Institutional animal care and use committee approval was obtained. Healthy T o reduce the side effects of axillary lymph node dissection, sentinel lymph node (SLN) biopsy (SLNB) has become the standard method for staging disease in patients with breast cancer ( 1 ) . Although SLNB with blue dye and/or radioactive tracers has an identifi cation rate of 90%-95% and a sensitivity of 88%-95%, these methods involve the use of ionizing radiation and are invasive (2,3). Moreover, they can fail to help identify axillary disease owing to a false negative rate of 5%-10% ( 2,3 ). Furthermore, while SLNB is less invasive than axillary lymph node dissection, it still poses a risk of postoperative complications: seroma formation, lymphedema, and motion limitation ( 4 ). As an alternative to SLNB, ultrasonographically (US)-guided fi ne-needle aspiration biopsy (FNAB) has been utilized ( 5 ). Although US-guided FNAB is less invasive, this technique requires accurate identifi cation of the SLN. Therefore, there is still a pressing need to develop an accurate, nonionizing, and noninvasive detection method for lymph node assessment. In addition to lymph node assessment in tumor studies, lymphatic vessels play an important role in lymphatic metastasis ( 6, 7 ) . Although both lymphatic and vascular systems contribute to tumor metastasis, the studies of lymphatic systems have been hindered by technical limitations. Fluorescence optical microscopy ( 8 ) successfully images lymphatic capillaries but suffers from poor spatial resolution because of strong light scattering in relatively deep tissues.
Photoacoustic imaging (Appendix E1 [online]) is an emerging hybrid modality that can provide strong endogenous and exogenous optical absorption contrasts with high ultrasonic spatial resolution ( 9, 10 ) . The image resolution, as
Implication for Patient Care
Volumetric spectroscopic photoan coustic imaging with ICG can potentially be used as a clinical tool for staging disease in patients with breast cancer.
Advance in Knowledge
Nonionizing volumetric spectron scopic photoacoustic imaging can noninvasively map sentinel lymph nodes and lymphatic vessels with high spatial resolution in healthy rats with the use of indocyanine green (ICG) in vivo. To investigate the feasibility of using ICG for volumetric in vivo mapping of SLNs and lymphatic vessels, the left axillae of fi ve rats were noninvasively imaged by using the photoacoustic imaging system ( Fig 2 ) . Prior to the administration of ICG, control images were obtained; a series of photoacoustic images was then acquired after the injection of ICG. We monitored the fi rst rat with photoacoustic imaging for 1 hour. The second rat was monitored for 3.2 hours to image the dynamics of SLNs and lymphatic vessels related to ICG injection, and the photoacoustic signals within those sites were quantifi ed by spatially averaging local photoacoustic signals. Two other rats were fi rst imaged for 1 hour to observe SLNs and lymphatic vessels and then used to observe image degradation with additional biologic tissues. The last rat was fi rst imaged for 2.2 hours and then used for spectroscopic photoacoustic imaging. The statistical analysis showing photoacoustic signal enhancement in SLNs and lymphatic vessels at 0.2 and 1 hour after injection was based on the imaging results in these fi ve rats. Photoacoustic signal enhancement was defi ned as the average photoacoustic signal intensity within the areas of SLNs and lymphatic vessels after ICG injection divided by the photoacoustic signal intensity within the same regions before injection.
Planar Fluorescence Imaging System and Experiment
The planar fl uorescence imaging system is shown in Figure 1b . The 784-nm, 80-mW light beam (Thorlabs, Newton, NJ) was expanded by a concave lens and illuminated the axilla of the animal. A fl uorescent band-pass fi lter (F10-830; CVI Laser, Albuquerque, NM) was mounted onto the front of a cooled charge-coupled device camera (BU401-BR; Andor Technology, South Windsor, Conn). Emitted fl uorescent light was collected by the camera. Three new rats were examined by using the fl uorescence imaging system; two for SLN mapping until 1 hour after ICG injection and one for the study of spatial resolution degradation with additional chicken breast tissue. We quantifi ed (V308; Panametrics-NDT, Waltham, Mass). The spatial resolutions at 19 mm deep in biologic tissues were 144 µm in the axial direction and 560 µm in the transverse direction ( 15 ) . One-dimensional (1D) depth-resolved (A-line) images were acquired by measuring the time of arrival of photoacoustic signals. By scanning targets in two transverse directions (yielding two-dimensional depth-resolved images, called B-scans), three-dimensional images, which represented the optical absorption heterogeneities of tissues, were formed. The acquired volumetric images were expressed in two forms: a maximum amplitude projection (MAP) image, which projected the maximum signal along each A-line onto the corresponding x-y plane, and a true volumetric image processed with software (Volview; Kitware, Clifton Park, NY). The scanning step sizes for the x and y directions were 200 and 400 µm, respectively. For a 25 3
Volumetric Photoacoustic Imaging System and Experiment
The volumetric photoacoustic imaging system is shown in Figure 1a ( 15 ) . The light was delivered from a tunable dye laser (ND6000; Continuum, Santa Clara, Calif) pumped by a Q-switched Nd:YAG laser (LS-2137; LOTIS, Minsk, Belarus) with a 6-nanosecond pulse duration and a 10-Hz pulse repetition rate. A light wavelength of 668 nm was used for most of the experiments, but both 618-and 668-nm optical wavelengths were used for spectroscopic SLN identifi cation. Formed by a concave lens, a spherical conical lens, and an optical condenser, the dark-fi eld light illumination was coaxially aligned with the US focus in water ( 16 ) . The light fl uence on the skin was 3.4 mJ/cm 2 , within the American National Standards Institute limit ( 17 ) . Generated photoacoustic waves were detected by a single-element 5-MHz US transducer 
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Kim et al pothesis was that the spatial resolution of the photoacoustic imaging system would be approximately maintained at the relatively low ultrasonic frequency even though the imaging depth was extended, since the resolution is determined by ultrasonic parameters ( 15 ) . However, the spatial resolution of fl uorescence imaging is expected to become worse because of strong light scattering. We compared the 1D profi les taken from each photoacoustic MAP image and planar fl uorescence image. Those 1D profi les were shifted and normalized according to the equation bg max bg S S S S , where S denotes the photoacoustic or fl uorescence for photoacoustic imaging and one rat for fl uorescence imaging, 1 hour after the ICG injection we added chicken breast tissue on top of the axillary region. Most SLNs are about 2 mm deep below the skin surface in the axillary region in rats. After we added one 3-4-mm-thick layer of chicken breast, the depth was increased to 5-6 mm. By adding a second 2-3-mm-thick layer of chicken breast, we extended the total depth to approximately 8 mm. Our hyfl uorescent signals by spatially averaging local fl uorescent intensities within the SLN for 1 hour after the injection in a rat. The error bars were based on the variation of fl uorescent intensities within the SLN.
Image Degradation Study with Additional Biologic Tissues
We examined the degradation of spatial resolution in both photoacoustic and fl uorescence images when the imaging depth was incremented. Using two rats 
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The photoacoustic signals in two lymphatic vessel locations were 1.08 AU 6 0.048 (location 1) and 1.09 AU 6 0.073 (location 2) at 0.2 hour after injection, which represented nineand 11-fold increases, respectively, over the values before injection. However, at 1.2 hours after injection, the signals (0.51 AU 6 0.034 for location 1 and 0.24 AU 6 0.001 for location 2) had decreased by 53% and 78%, respectively, from those at 0.2 hour after injection. In addition, after 1.5 hours, the photoacoustic signals from the SLN and the lymphatic vessels fl uctuated slightly, moving in opposition. These results can be explained by the compression and expansion phases of lymphatic vessels. Furthermore, the ICG started to diffuse to a second lymph node at 1.7 hours after injection ( Figure E1 [online]). Figure 2e shows the results of a statistical comparison of photoacoustic signal enhancement within the background, SLN, and lymphatic vessels at 0.2 and 1 hour after injection. In all fi ve rats imaged with photoacoustic imaging, SLNs were clearly visible, with a photoacoustic signal enhancement of 5.9 AU 6 1.8 (standard error of the mean) ( P , .002) at 0.2 hour after injection, while lymphatic vessels were seen in four of the fi ve rats, with a photoacoustic signal enhancement of 4.3 AU 6 0.6 ( P = .001). At 1 hour after injection, the photoacoustic signal enhancement from the SLN increased to 7.1 AU 6 2.2 ( P , .001), but the enhancement from the lymphatic vessels decreased to 1.9 AU 6 0.2 ( P = .13). The greenish lymph node dissected after photoacoustic imaging confi rmed ICG uptake ( Fig 2f ) , because normal lymph nodes do not have any green color.
Planar Fluorescence Imaging
By using the planar fl uorescence imaging system, the dynamics of ICG uptake by the SLN were monitored. A large amount of ICG was trapped by the lymphatic vessels right after the injection. As time passed, the fl uorescent signal within the SLN overwhelmed the signal from the lymphatic vessels and reached a steady state 40 minutes after the injection ( Fig 3 ) .
were used for the assessment of lymphatic vessels, since the lymphatic vessels were not visible in one experiment. The photoacoustic signal enhancement of SLNs and lymphatic vessels at 0.2 hour after injection was calculated, and then logarithmic transformation was applied to the photoacoustic signal enhancement for a better satisfaction of the normality assumption. Student paired t tests were performed to compare the pre-and postinjection differences. Note that the use of the paired t test based on a logarithmic scale was also equivalent to testing whether the photoacoustic signal enhancements (ie, the fold changes) of SLNs and lymphatic vessels were equal to 1. Statistical analyses were performed by using standard software (SAS, version 9; SAS Institute, Cary, NC). A P value of less than .05 was considered to indicate a signifi cant difference, and all statistical tests were two sided. Figure 2a shows the control image in one rat before the administration of ICG; the image depicts the surrounding vascular structures. The average photoacoustic signal enhancement from blood vessels was 5.1 AU 6 0.7 (standard error of the mean) ( Figure E2 [online]). In Figure 2b , the SLN and lymphatic vessels, along with the surrounding blood vessels, are clearly shown at 0.2 hour after injection. Figure 2c shows a volumetric rendering of the data at 0.7 hour after injection ( Figure E1 [online]). In addition to the SLN and lymphatic vessels, the functioning of the lymphatic valves can be inferred because lymphatic vessels were expanded immediately after the injection of ICG and then compressed. The photoacoustic signal in the SLN at 0.2 hour after injection was 0.96 AU 6 0.038 (standard deviation), a 7.4-fold increase over the value of 0.13 AU 6 0.13 before injection ( Fig  2d and Figure E1 [online]). Furthermore, the signal (1.13 AU 6 0.038) at 1.2 hours after injection had increased by 18% over the signal at 0.2 hour afsignal, S max denotes the maximum signal, and S bg denotes the background signal. The full widths at half maximum (FWHMs) of those 1D profi les, which were closely correlated with the spatial resolutions of both imaging systems, were estimated.
Results
Volumetric Photoacoustic Imaging
Spectroscopic Photoacoustic Imaging
Prior to the injection of ICG, the SLN and lymphatic vessels were not visible in control images. After the injection of ICG, the SLN and lymphatic vessels were diffi cult to distinguish from the surrounding blood vasculature without a proper control image. However, the SLN and lymphatic vessels can be distinguished from the surrounding blood vasculature by collecting images at two wavelengths (668 and 618 nm) after ICG injection. Because of the different absorption coeffi cients of blood and ICG at these optical wavelengths, lymphatic structures can be effectively differentiated from blood vessels by comparing the images acquired. First, we imaged the axillary region of one rat at 668 nm until 2.2 hours after the injection, and then we imaged the same region at 618 nm. After that, we switched the wavelength back to 668 nm to confi rm that the disappeared photoacoustic signals within the SLNs came from the wavelength switch instead of from ICG clearance. We quantifi ed photoacoustic signals by spatially averaging local photoacoustic amplitudes within the SLN and the adjacent blood vessels for 3.2 hours after the injection. The error bars were based on the variation of the photoacoustic signals within the SLN and blood vessels. Blood has more absorption at 618 nm than at 668 nm ( 18 ) , so the photoacoustic signals at 618 nm were expected to be stronger in blood. However, ICG has much less absorption at 618 nm than at 668 nm ( 14 ) , so the photoacoustic signals in ICG-dyed SLNs at 668 nm were expected to be stronger.
Statistical Analysis
The results from all fi ve rats imaged with photoacoustic imaging were used for the statistical assessment of SLNs, whereas the results from only four rats imaged with photoacoustic imaging
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Food and Drug Administration-approved dye for determining human cardiac output, hepatic function, and blood fl ow and for ophthalmic angiography. Unlike methylene blue, it has less potential for chemical side effects and photodamage. By applying a spectroscopic approach, this photoacoustic imaging system is potentially more useful in clinical conditions. Images from both techniques clearly show SLNs, lymphatic vessels, and the course and fl ow of lymphatic vessels. The lymphatic vessels are expanded and compressed passively by the periodic motion of adjunct structures. During the expansion, the initial lymphatic vessel traps a large amount of ICG owing to the opening of primary lymphatic valves, and this allows an infl ux of ICG to the initial lumen. At the same time, the secondary valve, the traditional intralymphatic valve, inside the initial channel is closed. During the compression, the secondary valve of the current lumen opens, and the dye is transported to the next lumen ( 19 ) . Although the fl uorescence images clearly show subcutaneous SLNs and lymphatic vessels, as Kitai et al ( 20 ) and Miyashiro a sudden increase right after the injection compared with the signal (0.05 AU 6 0.009) before injection, and slowly decreased as time passed. When the wavelength was changed to 618 nm, the photoacoustic signal decreased to 0.04 AU 6 0.007, close to the signal level seen with no ICG present. The signal again increased to 0.5 AU 6 0.02 after the wavelength was switched to 668 nm. In contrast, the photoacoustic signals within the adjacent blood vessel remained at 0.77 AU 6 0.03 at 668 nm, not showing any variation due to ICG injection. Then, the signal increased to 1.0 AU 6 0.013 when the wavelength was changed to 618 nm. The signal decreased to 0.73 AU 6 0.15 after the wavelength was switched to 668 nm. These variations agree well with the optical spectrum of blood.
Discussion
Using volumetric spectroscopic photoacoustic and planar fl uorescence imaging, we have demonstrated the feasibility of noninvasive in vivo dual-modality mapping of SLNs and lymphatic vessels with ICG. Unlike gold nanoparticles, ICG is a Figure 4 shows MAP and corresponding B-scan photoacoustic images at three different SLN depths after the injection. The SLNs are clearly seen in the MAP and B-scan images. The spatial resolution was fairly well maintained, although the imaging depth was increased. The average FWHM of the three 1D profi les in Figure 4b was 2.0 mm 6 0.2 (standard deviation), which is comparable to the measured size of a dissected lymph node. Figure 4c shows fl uorescent images at three SLN depths. As the imaging depth was extended, the fl uorescent images became blurred. The FWHMs of the three 1D profi les widened from 8 to 22 mm as the imaging depth increased ( Fig 4d ) .
Image Degradation Study with Additional Biologic Tissues
Spectroscopic Photoacoustic Imaging
The image representing subtraction of the 0.2-hour postinjection image at 668 nm from the 2.2-hour postinjection image at 618 nm showed the SLN and lymphatic vessels ( Fig 5 , Figure E3 [online]). The quantifi ed photoacoustic signal within the SLN was 1.0 AU 6 0.07 (standard deviation), which was of the described noninvasive dualmodality method of SLN identifi cation and percutaneous biopsy of the identifi ed SLNs would allow clinicians the ability to diagnose the presence or absence of malignancy and direct further treatment on the basis of those fi ndings. In summary, noninvasive dual-modality (volumetric spectroscopic photoacoustic and planar fl uorescence imaging) in vivo mapping of SLNs and lymphatic vessels using ICG as a contrast agent was successfully accomplished in rats. derivative dyes ( 13 ) need to be tested to take full advantage of the high molecular extinction of the dye and the optically optimal tissue transparent window at the near-infrared dye region.
Practical applications: The potential clinical implications are important. The ability to visualize the axillary SLNs in vivo permits the translation of this technology to the clinical realm. Imageguided biopsy of breast masses and lesions has become the standard of care. Although the use of standard axillary US is helpful in a subset of patients with breast cancer, it is only helpful if the patient is found to have morphologically abnormal axillary lymph nodes. To date, to our knowledge, there has not been a reliable method to identify the SLN noninvasively. The combination 
